Faruqi and Faruqui, LLP Logo
Share this page

Sinovac Biotech Ltd. (SVA)

NASDAQ:SVA

Summary

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Sinovac Biotech Ltd.  To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ:SVA).

The investigation focuses on whether the Company and its executives violated federal securities laws. Specifically, on December 21, 2016, Seeking Alpha published an article stating that the Chairman and CEO of Sinovac, Weidong Ying, paid bribes to Yin Hongzhang, the Deputy Director General of the Center for Drug Evaluation for the China Food and Drug Administration,  in order to help advance drug applications and evaluations.  Furthermore, on May 16, 2017, the Company issued a press release and filed a Form 6-K with the Securities and Exchange Commission (“SEC”), disclosing, among other things, that the SEC issued a subpoena requesting documents relating to the allegations referenced in the Seeking Alpha article. 

As a result of these disclosures, Sinovac’s share price declined, causing harm to investors.

If you invested in in Sinovac stock or options and would like to discuss your legal rights,please fill out the form below.  You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

Request Information

Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you.

  • Case:
    Sinovac Biotech Ltd. (SVA)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 05/17/2017

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.